Literature DB >> 19566519

Outcomes of minimally invasive surgery for phaeochromocytoma.

Goswin Y Meyer-Rochow1, Patsy S H Soon, Leigh W Delbridge, Mark S Sywak, Chris P Bambach, Roderick J Clifton-Bligh, Bruce G Robinson, Stan B Sidhu.   

Abstract

Laparoscopic adrenalectomy is now accepted as the procedure of choice for the resection of benign adrenocortical tumours, but few studies have assessed whether the outcomes of laparoscopic adrenalectomy for adrenal phaeochromocytoma are similar to that of other adrenal tumour types. This is a retrospective cohort study. Clinical and operative data were obtained from an adrenal tumour database and hospital records. A total of 191 patients had laparoscopic adrenalectomy, of which 36 were for phaeochromocytoma, over a 12-year period. Length of hospital stay (4.8 vs 3.6 days, P= 0.03) and total operating times (183 vs 157 min, P= 0.01) were greater in the laparoscopic phaeochromocytoma resection group. Despite the greater size of the phaeochromocytomas compared to the remaining adrenal tumour types (44 mm vs 30 mm, P < 0.01), however, rate of conversion and morbidity were no different. Laparoscopic adrenalectomy for phaeochromocytoma is a safe procedure with similar outcomes to laparoscopic adrenalectomy for other adrenal tumour types.

Entities:  

Mesh:

Year:  2009        PMID: 19566519     DOI: 10.1111/j.1445-2197.2009.04891.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  3 in total

Review 1.  Has laparoscopy impacted the indications for adrenalectomy?

Authors:  David W Hall; Jay D Raman
Journal:  Curr Urol Rep       Date:  2010-03       Impact factor: 3.092

2.  SAGES guidelines for minimally invasive treatment of adrenal pathology.

Authors:  Dimitrios Stefanidis; Melanie Goldfarb; Kent W Kercher; William W Hope; William Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

3.  Safety and feasibility of laparoscopic resection for large (≥ 6 CM) pheochromocytomas without suspected malignancy.

Authors:  Yvette M Carter; Haggi Mazeh; Rebecca S Sippel; Herbert Chen
Journal:  Endocr Pract       Date:  2012 Sep-Oct       Impact factor: 3.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.